What is Exactus, Inc. (EXDI) stock price today?

Exactus, Inc. (EXDI) is currently trading at $0.07, up 0% today.

What is EXDI P/E ratio?

Exactus, Inc.'s P/E ratio is -0.32. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is EXDI return on equity (ROE)?

Exactus, Inc.'s return on equity (ROE) is 366.67%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

OTC · Drug Manufacturers - Specialty & Generic

Exactus, Inc. (EXDI) Stock

$0.07 +0.00% OTC: EXDI Healthcare

Exactus, Inc. is a leading producer and supplier, specializing in ingredients derived from hemp as well as cutting-edge feminized hemp genetics.

Valuation

Metric	Value
Price	$0.07
Market Cap	$0
P/E Ratio	-0.32
P/B Ratio	-1.07
P/S Ratio	0.00
EPS (TTM)	$-0.22
52-Week High	$0.07
52-Week Low	$0.05
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	366.67%
ROA	366.67%
ROCE	136.72%
Gross Margin	-333.33%
Operating Margin	-366.67%
Net Margin	-366.67%
Debt/Equity	0.00
Current Ratio	0.01

Annual Financials (USD)

Metric	2016	2017	2018	2019	2020
Revenue	$0	$0	$0	$0	$3.0M
Operating Profit	$-2.0M	$-2.0M	$-2.0M	$-11.0M	$-11.0M
Net Profit	$-2.0M	$-4.0M	$-4.0M	$-10.0M	$-11.0M
EPS	$-0.67	$-0.91	$-0.91	$-0.29	$-0.22
Op Margin	—	—	—	-3146.8%	-388.1%

Balance Sheet (USD)

Metric	2016	2017	2018	2019	2020
Total Assets	$2.0M	$0	$0	$10.0M	$-3.0M
Total Liabilities	$1.0M	$2.0M	$3.0M	$6.0M	$5.0M
Cash	$1.0M	$0	$0	$0	$0
Borrowings	$0	$0	$1.0M	$1.0M	$0

Latest News

Micron and Sandisk Are Surging: Can the Rally Last Through 2027? Motley Fool · Jul 23, 2026 Net Asset Value(s) Business Wire · Jul 23, 2026 Retiring With Lots of Savings? 2 Social Security Claiming Strategies to Look At. Motley Fool · Jul 23, 2026 Arista Networks Insider Sold Shares Worth $7,388,872, According to a Recent SEC Filing MT Newswires · Jul 23, 2026 Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric	2016	2017	2018	2019	2020
Operating Cash Flow	$-1.0M	$-1.0M	$0	$-6.0M	$-1.0M
Investing Cash Flow	$0	$0	$0	$-3.0M	$0
Financing Cash Flow	$2.0M	$0	$0	$8.0M	$1.0M
Net Cash Flow	$1.0M	$-1.0M	$0	$0	$0
Free Cash Flow	$-1.0M	$-1.0M	$0	$-6.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.01
FCF Yield	—
Quick Ratio	0.01
Interest Coverage	-10.52
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACRDFAcreage Holdings, Inc.	$0.12	+2.52%	-0.01	$4.88M	0.00%
BCBCFThe BC Bud Corporation	$0.04	-3.31%	-1.92	$5.98M	0.00%
CHNCChina Infrastructure Construction Corp.	$0.00	—	0.03	$5.04M	0.00%
CLSHCLS Holdings USA, Inc.	$0.04	+0.00%	-0.79	$5.94M	0.00%
FLWPFThe Flowr Corporation	$0.00	—	—	$4265	0.00%

About Exactus, Inc.

Exactus, Inc. is a leading producer and supplier, specializing in ingredients derived from hemp as well as cutting-edge feminized hemp genetics. The company's offerings include feminized genetic strains rich in both cannabidiol (CBD) and high-cannabigerol (CBG). Beyond genetics, Exactus provides a comprehensive range of hemp-derived specialty ingredients, such as purified isolates of CBD, CBG, CBN, and CBC; potent CBD and CBG distillates; water-soluble CBD formulations; raw CBD and CBG biomass; dried CBD and CBG flowers; and CBD crude oil. They also offer white-label product solutions, serving a diverse clientele across the cosmetic, health and wellness, food and beverage, pharmaceutical, and pet care sectors. Exactus further extends its capabilities to custom manufacturing an assortment of cannabinoid-infused specialty products, including skincare items, pain relief creams, tinctures, bath bombs, soft gels, balms, pet-specific goods, and dietary supplements. The company's operations are based in Delray Beach, Florida, functioning as a subsidiary under Ceed2Med, LLC.

the stock is valued at a price-to-earnings (P/E) ratio of -0.32, price-to-book of -1.07, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.05 and $0.07, and currently trades at its 52-week high.

On profitability, Exactus, Inc. generates a return on equity (ROE) of 366.67% — well above the market average, a sign of a high-quality business, return on capital employed of 136.72%, an operating margin of -366.67%, a net profit margin of -366.67%.

Official website: www.exactushemp.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides